Home Cart Sign in  
Chemical Structure| 526-07-8 Chemical Structure| 526-07-8

Structure of Sesamolin
CAS No.: 526-07-8

Chemical Structure| 526-07-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Sesamolin is a furofuran lignan extracted from sesame seeds, which has beneficial physiological properties such as antioxidant, anti-mutagenic, anti-aging and anti-inflammatory activities. It was also found to inhibit lipid peroxidation in rat liver and kidney.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Sesamolin

CAS No. :526-07-8
Formula : C20H18O7
M.W : 370.35
SMILES Code : [H][C@@]12[C@@](CO[C@@H]2C3=CC=C(OCO4)C4=C3)([H])[C@@H](OC5=CC=C(OCO6)C6=C5)OC1
MDL No. :MFCD04112844
InChI Key :ZZMNWJVJUKMZJY-AFHBHXEDSA-N
Pubchem ID :101746

Safety of Sesamolin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317
Precautionary Statements:P261-P272-P280-P302+P352-P333+P313-P321-P363-P501

Related Pathways of Sesamolin

MAPK
pyroptosis
TLR

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
GH3 cells 10 μM 1 min Inhibited the peak and sustained components of voltage-gated Na+ currents (INa) PMC7411736
GH3 cells 3 μM 1 min Inhibited the peak and sustained components of voltage-gated Na+ currents (INa) PMC7411736
MDCK-MDR1 cells 20 μM 120 minutes To assess the membrane permeability of Sesamolin, results showed high permeability coefficient (20.53 × 10–6 cm/s) and it is not a substrate of efflux transporters PMC9722955
Neuro-2a-CYP46A1 cells 20 μM 24 hours To evaluate the effect of Sesamolin on CYP46A1 protein expression, results showed Sesamolin significantly reduced CYP46A1 protein levels by 57.1% PMC9722955
Bone marrow macrophages (BMMs) 0, 2.5, 5, 10 μM 5 days Sesamolin inhibited RANKL-induced osteoclast formation in a dose-dependent manner PMC8237092
Bone marrow macrophages (BMMs) 10 μM Different stages (early: day 1-3, middle: day 3-5, late: day 5-7) Sesamolin mainly inhibited osteoclast differentiation in the early and middle stages, especially in the early stage (day 1-3) PMC8237092

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
BALB/c nude mice Endometrial cancer xenograft model Oral 30 mg/kg and 60 mg/kg To assess the therapeutic effect of Sesamolin on endometrial cancer xenografts, results showed that Sesamolin significantly inhibited tumor growth without obvious toxicity. PMC11067147
C57BL/6J mice Ovariectomized (OVX)-induced osteoporosis model Intraperitoneal injection 5 mg/kg Every two days for 42 days Sesamolin effectively reduced bone loss caused by estrogen deficiency and showed no significant toxic effects on the heart, liver, spleen, or kidney PMC8237092
Mice High-fat and high-fructose diet-induced nonalcoholic fatty liver disease model Oral 60 mg/kg Twice a day for 4 weeks Sesamolin alleviates nonalcoholic fatty liver disease through modulating gut microbiota and metabolites in high-fat and high-fructose diet-fed mice. Sesamolin effectively suppressed obesity-associated metabolic disorder, attenuated hepatic steatosis and the infiltration of inflammatory cells, and decreased levels of hepatic proinflammatory cytokines. PMC9694049

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.70mL

0.54mL

0.27mL

13.50mL

2.70mL

1.35mL

27.00mL

5.40mL

2.70mL

 

Historical Records

Categories